Nucleome Therapeutics Limited
Nucleome Therapeutics Limited specializes in decoding the dark genome to develop first-in-class precision medicines. Their innovative approach aims to unlock new therapeutic avenues for complex diseases.
Founded: 17 Jul 2019
Industries:
72110 - Research and experimental development on biotechnology
Website: nucleome.com
Phone: +441865346060
Email: careers@nucleome.com
Location: Oxford
Products & Services
• biotechnology company
• dark genome
• precision medicine
• precision medicines development
• therapeutics
• therapeutics targeting the dark genome
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
9
Shareholders
30
Controllers (PSC)
2
Fiona Caroline Maclaughlin
Director • British • Lives in England • Born in Apr 1971
Jonathan Paul Hepple
Director • British • Lives in United Kingdom • Born in Apr 1971
James Raymond Hughes
Director • British,irish • Lives in United Kingdom • Born in Sept 1968
Bauke Anninga
Director • Dutch • Lives in Netherlands • Born in Dec 1986
Rana Abdul Raouf Al-hallaq
Director • American • Lives in United States • Born in Jun 1975
Registered Office Address
Nucleome Therapeutics Limited, Inventa
Botley Road
Oxford
OX2 0HA
United Kingdom
Basic Information
LTD
17 Jul 2019
ENGLAND WALES
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
12
Officers
2
PSCs
0
Filings